Published in Neuropeptides on May 17, 2011
Anesthetics isoflurane and desflurane differently affect mitochondrial function, learning, and memory. Ann Neurol (2012) 1.76
Delivery of iPS-NPCs to the Stroke Cavity within a Hyaluronic Acid Matrix Promotes the Differentiation of Transplanted Cells. Adv Funct Mater (2014) 0.88
The mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell death. Front Oncol (2014) 0.87
Propofol and magnesium attenuate isoflurane-induced caspase-3 activation via inhibiting mitochondrial permeability transition pore. Med Gas Res (2012) 0.82
Mechanisms of mitochondrial damage in keratinocytes by pemphigus vulgaris antibodies. J Biol Chem (2013) 0.81
Behavioral and histopathological assessment of adult ischemic rat brains after intracerebral transplantation of NSI-566RSC cell lines. PLoS One (2014) 0.79
Cyclosporine A Treatment Abrogates Ischemia-Induced Neuronal Cell Death by Preserving Mitochondrial Integrity through Upregulation of the Parkinson's Disease-Associated Protein DJ-1. CNS Neurosci Ther (2016) 0.78
ALDH2, a novel protector against stroke? Cell Res (2013) 0.77
Skeletal muscle mitochondrial health and spinal cord injury. World J Orthop (2016) 0.77
Mitochondrial targets for pharmacological intervention in human disease. J Proteome Res (2014) 0.76
Battery of behavioral tests in mice to study postoperative delirium. Sci Rep (2016) 0.76
Knockout of Cyclophilin-D Provides Partial Amelioration of Intrinsic and Synaptic Properties Altered by Mild Traumatic Brain Injury. Front Syst Neurosci (2016) 0.75
Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke. Int J Mol Sci (2016) 0.75
Effect of Cyclosporine on Lesion Growth and Infarct Size within the White and Gray Matter. Front Neurol (2017) 0.75
Aspects on the Physiological and Biochemical Foundations of Neurocritical Care. Front Neurol (2017) 0.75
Surgical management of trigeminal neuralgia: use and cost-effectiveness from an analysis of the Medicare Claims Database. Neurosurgery (2014) 1.98
Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor. Hypertension (2006) 1.80
Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol (2004) 1.47
Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection. Exp Neurol (2004) 1.40
Advancements in carotid stenting leading to reductions in perioperative morbidity among patients 80 years and older. Neurosurgery (2006) 1.38
Cell-based therapy in ischemic stroke. Expert Rev Neurother (2008) 1.33
Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. PLoS One (2013) 1.33
Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. BMC Neurosci (2009) 1.33
Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci (2013) 1.31
Severity of controlled cortical impact traumatic brain injury in rats and mice dictates degree of behavioral deficits. Brain Res (2009) 1.27
Microglia activation as a biomarker for traumatic brain injury. Front Neurol (2013) 1.23
Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J Cereb Blood Flow Metab (2008) 1.22
Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev (2009) 1.18
Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells Dev (2010) 1.17
Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Prog Neurobiol (2008) 1.15
Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med (2008) 1.13
Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant (2009) 1.12
The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention. J Neuroinflammation (2012) 1.12
Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant (2006) 1.10
Surgical management of moyamoya disease: a review. Neurosurg Focus (2009) 1.08
In vivo animal stroke models: a rationale for rodent and non-human primate models. Transl Stroke Res (2013) 1.07
Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension (2003) 1.05
Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats. PLoS One (2012) 1.05
Quantitative analyses of matrix metalloproteinase activity after traumatic brain injury in adult rats. Brain Res (2009) 1.02
Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells. Curr Pharm Des (2012) 1.01
Amnion: a potent graft source for cell therapy in stroke. Cell Transplant (2009) 1.01
The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells. Cell Transplant (2010) 1.00
Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Hum Gene Ther (2006) 0.99
Immediate, but not delayed, microsurgical skull reconstruction exacerbates brain damage in experimental traumatic brain injury model. PLoS One (2012) 0.99
Recent Studies Assessing the Proliferative Capability of a Novel Adult Stem Cell Identified in Menstrual Blood. Open Stem Cell J (2011) 0.99
Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site. PLoS One (2013) 0.98
Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy. Cell Transplant (2010) 0.97
Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease. J Cell Physiol (2015) 0.96
Vasculogenesis in experimental stroke after human cerebral endothelial cell transplantation. Stroke (2013) 0.95
Dietary supplementation exerts neuroprotective effects in ischemic stroke model. Rejuvenation Res (2008) 0.93
Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survival. Hum Gene Ther (2004) 0.93
Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. Stem Cells Dev (2005) 0.93
Traumatic brain injury precipitates cognitive impairment and extracellular Aβ aggregation in Alzheimer's disease transgenic mice. PLoS One (2013) 0.93
The frontotemporal-orbitozygomatic approach: reconstructive technique and outcome. Acta Neurochir (Wien) (2012) 0.91
Do bone marrow cells generate neurons? Arch Neurol (2004) 0.91
A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem Cells. Transl Stroke Res (2011) 0.91
Amniotic fluid stem cells: a promising therapeutic resource for cell-based regenerative therapy. Curr Pharm Des (2012) 0.90
Transplantation of post-mitotic human neuroteratocarcinoma-overexpressing Nurr1 cells provides therapeutic benefits in experimental stroke: in vitro evidence of expedited neuronal differentiation and GDNF secretion. J Neurosci Res (2007) 0.90
Graft selection in cerebral revascularization. Neurosurg Focus (2009) 0.89
Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke. Neurosci Biobehav Rev (2011) 0.88
Frequency and management of recurrent stenosis after carotid artery stent implantation. J Neurosurg (2005) 0.88
Oxygen-glucose-deprived rat primary neural cells exhibit DJ-1 translocation into healthy mitochondria: a potent stroke therapeutic target. CNS Neurosci Ther (2013) 0.87
Differential response to ischemia in adjacent hippocampalsectors: neuronal death in CA1 versus neurogenesis in dentate gyrus. Biotechnol J (2007) 0.87
Transplantation of cryopreserved human bone marrow-derived multipotent adult progenitor cells for neonatal hypoxic-ischemic injury: targeting the hippocampus. Rev Neurosci (2006) 0.87
Postischemic infusion of adrenomedullin protects against ischemic stroke by inhibiting apoptosis and promoting angiogenesis. Exp Neurol (2005) 0.87
Intravenous infusion of GDNF gene-modified human umbilical cord blood CD34+ cells protects against cerebral ischemic injury in spontaneously hypertensive rats. Brain Res (2010) 0.86
Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for Stroke. Transl Stroke Res (2015) 0.86
Stem cell transplantation for neuroprotection in stroke. Brain Sci (2013) 0.85
Evolution in the assessment and management of trigeminal schwannoma. Laryngoscope (2008) 0.85
Pediatric intracranial aneurysms: current national trends in patient management and treatment. Childs Nerv Syst (2013) 0.85
Systemic delivery of umbilical cord blood cells for stroke therapy: a review. Restor Neurol Neurosci (2009) 0.84
Cerebral aneurysm as an exacerbating factor in stroke pathology and a therapeutic target for neuroprotection. Curr Pharm Des (2012) 0.84
Toward personalized cell therapies: autologous menstrual blood cells for stroke. J Biomed Biotechnol (2011) 0.83
Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction. J Stem Cell Res Ther (2013) 0.83
Stem Cells for Neurovascular Repair in Stroke. J Stem Cell Res Ther (2013) 0.83
Neurological disorders and the potential role for stem cells as a therapy. Br Med Bull (2012) 0.83
Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: a new perspective to neuroprotection. J Pineal Res (2011) 0.83
Vascular damage: a persisting pathology common to Alzheimer's disease and traumatic brain injury. Med Hypotheses (2013) 0.83
Transplantation of carotid body cells in the treatment of neurological disorders. Neurosci Biobehav Rev (2005) 0.83
Adult stem cell therapy for acute brain injury in children. CNS Neurol Disord Drug Targets (2008) 0.83
The changing face of acoustic neuroma management in the USA: analysis of the 1998 and 2008 patient surveys from the acoustic neuroma association. Br J Neurosurg (2013) 0.82
Field of view comparison between two-dimensional and three-dimensional endoscopy. Laryngoscope (2013) 0.82
α-Synuclein is a pathological link and therapeutic target for Parkinson's disease and traumatic brain injury. Med Hypotheses (2013) 0.82
ADVANCES IN THE CELL-BASED TREATMENT OF NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURY. Future Neurol (2013) 0.82
Stem cell research in cell transplantation: sources, geopolitical influence, and transplantation. Cell Transplant (2010) 0.82
Nestin overexpression precedes caspase-3 upregulation in rats exposed to controlled cortical impact traumatic brain injury. Cell Med (2012) 0.82
Stem cell transplants at childbirth. Stem Cell Rev (2010) 0.82
No pain, no gain--exercise-induced rhabdomyolysis associated with the performance enhancer herbal supplement ephedra. Med Sci Monit (2006) 0.82
Stem cells have the potential to rejuvenate regenerative medicine research. Med Sci Monit (2010) 0.82
Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier. Cell Transplant (2014) 0.82
Effects of voluntary physical exercise, citicoline, and combined treatment on object recognition memory, neurogenesis, and neuroprotection after traumatic brain injury in rats. J Neurotrauma (2015) 0.82
Developments in intracerebral stem cell grafts. Expert Rev Neurother (2015) 0.81
Intracerebral transplantation of carotid body in rats with transient middle cerebral artery occlusion. Brain Res (2004) 0.81
Human second trimester amniotic fluid cells are able to create embryoid body-like structures in vitro and to show typical expression profiles of embryonic and primordial germ cells. Cell Transplant (2014) 0.81
G-CSF as an adjunctive therapy with umbilical cord blood cell transplantation for traumatic brain injury. Cell Transplant (2015) 0.81
Peri-hemorrhagic degeneration accompanies stereotaxic collagenase-mediated cortical hemorrhage in mouse. Brain Res (2010) 0.81
In vitro non-viral lipofectamine delivery of the gene for glial cell line-derived neurotrophic factor to human umbilical cord blood CD34+ cells. Brain Res (2010) 0.80
Transplantation of human umbilical cord blood cells in the repair of CNS diseases. Expert Opin Biol Ther (2004) 0.80
A review of laboratory and clinical data supporting the safety and efficacy of cyclosporin A in traumatic brain injury. Neurosurgery (2011) 0.80